IPO - JUPITER NEUROSCIENCES, INC.

Form Type: 8-K

Filing Date: 2025-07-09

Corporate Action: Ipo

Type: New

Accession Number: 000164117225018429

Filing Summary: On July 2, 2025, Jupiter Neurosciences, Inc. approved a bonus package for certain executive officers as a reward for their contributions to the company's successful initial public offering (IPO) completed in December 2024. The Compensation Committee's package included stock options for Alison Silva, Chief Business Officer (255,320 options), and Saleem Elmassri, Chief Financial Officer (102,128 options), with an exercise price of $1.19 per share. These options vest in equal installments over three years, contingent upon continued employment. Additionally, cash bonuses were set for several officers, contingent on the company maintaining over $3,500,000 in cash, including a $210,000 bonus for CEO Christer Rosén, and additional amounts for other executives and Titan Advisory Services.